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Five to 15% of patients with carotid territory transient ischemic attacks or cerebral
infarctions have complete occlusion of the internal carotid artery.1,2 Their risk of recurrent
stroke during the next two years while on medical therapy is 5–9% per year for all stroke
and 2–8% per year for ipsilateral ischemic stroke. 3–6 Debate on the best means to prevent
recurrence has centered on whether embolic or hemodynamic mechanisms are most
important. In the late 1970s and early 1980s, embolism of atherothrombotic material from
the persisting proximal stump of the occluded internal carotid artery through external carotid
artery collaterals was put forward as the most common cause for recurrent cerebral ischemic
events.7,8 At this same time, extracranial-intracranial (EC-IC) bypass was increasingly used
to try to prevent recurrent stroke by improving the hemodynamic status of the cerebral
circulation distal to the occluded vessel.9,10 From 1977–1985, an international, multicenter,
randomized trial was conducted to determine the efficacy of EC-IC bypass for the
prevention of subsequent stroke. Among 808 randomized patients with symptomatic carotid
occlusion, no benefit of surgery was demonstrated.11 Some concluded that the reason for the
negative results was that the majority of strokes were due to emboli whereas others
criticized the trial for failing to identify patients with hemodynamic cerebral ischemia due to
poor collateral circulation for whom surgical revascularization would be of benefit.12,13
However, the pattern of arteriographic collaterals failed to identify a subgroup who
benefitted from surgery.14
At the time of the EC-IC Bypass Study, there was no reliable method for assessing the
hemodynamic effects of carotid artery occlusion on the cerebral circulation. While direct
measurements of arterial-jugular venous oxygen differences had demonstrated that
reductions in whole brain cerebral blood flow (CBF) by induced systemic hypotension led to
an increase in cerebral oxygen extraction fraction (OEF), jugular sampling was not useful
for assessing the hemodynamic effects of unilateral carotid occlusion.15,16
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where CMRO2 is the cerebral metabolic rate of oxygen, CBF is the cerebral blood flow and
CaO2 is the arterial oxygen content.
OEF reflects the balance between oxygen utilization (CMRO2) and oxygen delivery (CBF x
CaO2). Normal OEF is 30–40%. When whole brain CBF decreases, OEF increases as much
as two-fold. The invention of positron emission tomography (PET) in the early 1980s made
it possible to measure regional cerebral OEF in vivo. Because of the close coupling between
regional flow and metabolism in the resting brain, OEF is normally quite uniform (Figure
1).17–19 In 1981, Jean-Claude Baron and colleagues described a patient with carotid artery
occlusion and focally increased OEF in the ipsilateral cerebral hemisphere. They proposed
the term “misery perfusion” to describe this condition.20
At Washington University in the early 1980s, we began to study patients with carotid artery
occlusion using PET measurements of OEF to assess the hemodynamic status of the cerebral
circulation in the ipsilateral middle cerebral artery (MCA) territory. In some, OEF in the
MCA territory distal to the occlusion was normal indicating collateral circulation maintained
the normal balance between oxygen delivery and metabolism. In others, a regional increase
in OEF indicated poor collateral circulation with chronically reduced CBF relative to
CMRO2 (Figure 1).21
From 1992–1997, we carried out the St. Louis Carotid Occlusion Study to determine if
increased OEF in the cerebral hemisphere distal to symptomatic carotid artery occlusion was
an independent predictor of the subsequent stroke in medically treated patients.5 Major
eligibility criteria were: (1) Occlusion of one or both common or internal carotid arteries and
(2) Transient ischemic neurological deficits (including transient monocular blindness) or
mild to moderate stroke in the appropriate carotid artery territory. Just prior to PET, each
subject underwent neurological evaluation and assessment of the baseline risk factors.
Quantitative regional OEF was measured by PET.22 When technical difficulties precluded
collection of the arterial time activity curves necessary to determine quantitative OEF, the
ratio image of the counts in the unprocessed images of O15O and H215O was substituted.
The left/right MCA OEF ratio was calculated from non-infarcted tissue. Ratios from 18
normal control subjects defined the normal range for OEF. A separate normal range for
count-based O15O/H215O ratio images was determined. No information regarding the PET
results was provided to patients, treating physicians or the investigator responsible for
determining endpoints
The primary endpoint was ischemic stroke defined clinically as a neurological deficit of
presumed ischemic cerebrovascular cause lasting greater than 24 hours in any
cerebrovascular territory. Secondary endpoints were ipsilateral ischemic stroke and death.
Patients with subsequent cerebrovascular surgery were censored at the time of surgery.
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Eighty-one subjects were enrolled and followed through telephone contact every six months.
Medical treatment on a monthly basis was recorded. Symptoms suggesting a stroke were
evaluated by the designated blinded investigator using history from the patient or eyewitness
and review of medical records. If necessary, follow-up examination and brain imaging were
arranged. All living patients were followed for the duration of the study. Mean follow-up
was 31.5 months.
Of the 81 patients, 39 had ipsilateral increased OEF and 42 did not. The two groups were
well matched for baseline risk factors except that retinal symptoms were less common in the
high OEF group. Arteriographic collateral circulation did not permit identification of the
high OEF group. In the 39 high OEF subjects, 12 total and 11 ipsilateral strokes occurred. In
the 42 subjects with normal OEF, there were 3 total and 2 ipsilateral strokes. The rates for
all stroke and ipsilateral ischemic stroke in high OEF subjects were significantly higher than
in those with normal OEF (p=.005 and p=.004, respectively). (Table 1, Figure 2) After
adjustment for 17 baseline patient characteristics and interval medical treatment, the relative
risk conferred by high OEF was 6.0 (95% CI 1.7–21.6) for all stroke and 7.3 (95% CI 1.6–
33.4) for ipsilateral stroke.
Arterial time-activity data was not available in 13 of 81 subjects and the count-based ratio
was substituted. Subsequently, we analyzed the count-based method ratio for all 81 patients.
All 13 ipsilateral ischemic strokes occurred in the 50 patients with increased count-based
OEF (p = .002) The count-based ratio method was a better predictor of subsequent stroke
than ipsilateral quantitative OEF measurements or quantitative ratios.23 The quantitative and
count-based OEF ratio methods were each significant predictors of stroke risk when
analyzed as a continuous variable (both p < .02).24
Four additional published studies in symptomatic patients with carotid occlusion or
intracranial stenosis/occlusion have confirmed that PET measurements of OEF identify
patients at high risk for subsequent ipsilateral ischemic stroke while on medical therapy
(Table 2).25–28
Concurrently with the EC-IC Bypass Study, we and others demonstrated that EC-IC bypass
in patients with carotid occlusion and increased OEF could improve OEF and sometimes
return it to normal (Figure 1).20,21,29,30 In the absence of an empiric trial, however, it could
not be assumed that EC-IC bypass surgery would reduce the risk of subsequent stroke in this
group of patients. The morbidity and mortality due to surgery and the long-term stroke risk
in operated patients were not known.
The Carotid Occlusion Surgery Study (COSS) was a prospective, randomized, controlled,
blinded end-point clinical trial designed to determine whether EC-IC bypass could reduce
subsequent ipsilateral ischemic stroke at two years in participants with recent (≤120 days)
hemispheric symptoms from internal carotid artery occlusion and hemodynamic cerebral
ischemia identified by an ipsilateral increased OEF measured by PET.28 It was conducted at
49 clinical centers and 18 PET centers in the United States and Canada from 2002–2010.
The PET eligibility criterion was an ipsilateral-to-contralateral count-based OEF ratio
>1.130. Intra-arterial catheter arteriography documenting (1) occlusion of the symptomatic
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internal carotid artery and (2) intracranial and extracranial arteries suitable for anastomosis
was required. Peri-operative anti-thrombotic treatment for the surgical group was
determined by the COSS neurosurgeon. Otherwise all subjects remained on the anti-
thrombotic treatment preferred by their physicians. Target goals for risk factor control were:
130/85 mm Hg for blood pressure, 100 mg/dL for low density lipoprotein (LDL)-
cholesterol, 150 mg/dL for triglycerides and 7% for hemoglobin A1C. Referral to primary
physicians or directly to smoking cessation programs was encouraged.
The first follow-up visit was 30–35 days after randomization. All surgical participants
received a repeat PET scan 30–60 days post-operatively. Subsequent follow-up visits were
at three-month intervals after randomization until 24 months or the end of the trial.
The primary endpoint for all who were assigned to surgery and received surgery was the
combination of: (1) all stroke and death from surgery through 30 days post-surgery and (2)
ipsilateral ischemic stroke within two years of randomization. The primary endpoint in the
non-surgical group and for those assigned to surgery who did not receive surgery was the
combination of: (1) all stroke and death from randomization to randomization plus 30 days
and (2) ipsilateral ischemic stroke within two years of randomization. Ipsilateral ischemic
stroke was defined as the clinical diagnosis of a focal neurological deficit due to cerebral
ischemia clinically localizable within the territory of the symptomatic occluded internal
carotid artery that lasted for more than 24 hours. Final determination of stroke endpoints was
by a 3-person blinded Adjudication Committee.
COSS was stopped by the Data, Safety and Monitoring Board based on a futility analysis of
139 patients who had completed two-year follow-up; 195 total participants had been
randomized, 97 to the surgical group and 98 to the non-surgical group. Comparison of 24
baseline variables produced 1 difference at the p<.05 level as expected, in systolic blood
pressure. At last follow-up visit, risk factor control was similar in both groups.
Follow-up for the primary endpoint was 99% complete. All primary endpoints were
ipsilateral ischemic strokes, twenty in each group. For the intention-to-treat analysis of the
primary endpoint, two-year rates were .210 for the surgical group and .227 for the non-
surgical group (p=0.78). (Figure 3A) COSS was designed with 90% power to detect 16%
absolute risk reduction. The final results excluded with greater than 95% confidence a
benefit for surgery this large.
There was no significant benefit for surgery on any of the COSS secondary outcome
measures. The Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)
trial performed on a subset of COSS patients showed no difference in 2-year cognitive
change between the surgical and non-surgical groups (p = .9). The number of subjects
studies for RECON met the pre-study power calculation for detecting a large effect size of a
difference of 0.8 SD in composite cognitive change score between treatment arms. It is
possible that greater numbers of patients may have demonstrated a small or moderate
superiority of one treatment arm or the other, although with the point estimate near zero this
would have been unlikely. The 95% confidence interval was −0.5 to 0.5 SD, the limits of a
moderate effect size 31
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COSS was designed with a two-year endpoint. Trials of medically treated symptomatic large
artery atherosclerosis have shown a major decrease in stroke rate after two years. In the EC-
IC Bypass Study, the stroke rate at 2 years was 20% but at 4 years the stroke rate had only
increased by an additional 6%.11 In the carotid endarterectomy trials, the stroke rate at two
years for 70–99% stenosis was 20% but increased only by an additional 4% by year 4.32
Data reported by Persoon and colleagues from 117 patients with symptomatic internal
carotid artery occlusion show a recurrent ischemic stroke rate of 12% at 2 years, increasing
to only 14% by 4 years.33 Continuing COSS for an additional three years with a 1–3%/year
rate of stroke in the non-surgical group would not have resulted in a statistically significant
benefit for surgery, even if no additional strokes occurred in the surgical group.
A subsequent subgroup analysis of 36 subjects in St. Louis Carotid Occlusion Study who
met the clinical eligibility criteria for COSS confirmed the superiority of the count-based
ratio OEF method to determine eligibility. The risk of ipsilateral stroke in patients who met
the COSS ratio criteria (7/18, 39%) was virtually identical to those with quantitative OEF
threshold of ≥ 50% (4/10, 40%) but the COSS ratio method identified more patients (7/9)
who would go on to develop a stroke than the absolute OEF criteria (4/9). 34
In the COSS surgical group, 30-day graft patency was 98% and patency at last follow-up
was 96%. Mean OEF ratio improved from 1.258 to 1.109. Of 20 strokes in the surgical
group, 14 occurred in the 30 day post-operative period. This peri-operative stroke rate of
15% was not significantly different from the international EC-IC Bypass Trial.11 Twelve of
these post-operative strokes occurred within 2 days of surgery. Eliminating these 12 strokes,
the subsequent stroke rate in the remainder of the surgical group was .09, significantly less
than the non-surgical group (p=.02).(Figure 3B)
COSS demonstrated the importance of cerebral hemodynamics in the treatment of carotid
occlusion. The pathophysiological hypothesis was correct. Surgical improvement of
hemodynamics by EC-IC bypass reduced stroke risk. However, the cure was as bad as the
disease. The peri-operative stoke rate was sufficiently high to nullify any benefit. Extensive
post-hoc analyses failed to define any patient, procedural or surgeon characteristic that
predicted who would have a peri-operative stroke.35
COSS demonstrated that EC-IC bypass provides no benefit over medical management for
stroke prevention in patients with symptomatic carotid artery occlusion, even on those with
increased OEF. However, disagreement existed whether strict blood pressure control was the
best for these patients or if higher blood pressures were needed to preserve cerebral
perfusion and prevent subsequent stroke.1,36 To address this issue, we analyzed data from
the non-surgical group of COSS.37
Of 98 non-surgical participants, 91 were included in the analysis: three had no post-
randomization blood pressures recorded, and four had ipsilateral ischemic strokes before the
first blood pressure recording at the 30–35 day follow-up visit. We compared the occurrence
of ipsilateral ischemic stroke during follow-up in the 41 subjects with mean blood pressures
during follow-up who met the COSS target ≤ 130/85 mm Hg to the remaining 50 with
higher blood pressures. We used only the blood pressures recorded before the stroke
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occurred for those who experienced an endpoint ipsilateral ischemic stroke. For all others
we used all recorded blood pressure measurements. The groups were well-matched for
baseline characteristics and medical management during follow-up except for the time from
entry event to randomization, which was not a significant predictor of subsequent stroke in
these 91 patients (p = .32).
Of 16 ipsilateral ischemic strokes within two years of randomization, 3 occurred in the 41
subjects with mean follow-up blood pressure of ≤ 130/85 compared to 13 in the remaining
50 subjects with mean follow-up blood pressures >130/85 (hazard ratio 3.74, 95% CI 1.07–
13.15, p = 0.027). (Figure 4) The two-year Kaplan-Meier estimated rates were .082 and .
304, respectively. In the subgroup of 52 subjects who were always taking at least one
antihypertensive drug at every follow-up visit, there were 2 strokes in 23 patients in the
≤130/85 group and 10 strokes in 32 subjects in the >130/85 group (hazard ratio 3.78, 95%
CI .83–17.30, p=0.065 log-rank). The hazard ratio of 3.78 for this always treated subgroup
was essentially identical to that of 3.74 for the primary analysis. There was no evidence of a
J-curve.38
This was not a randomized trial of different targets for blood pressure control. Nevertheless,
this study provided Class III evidence by American Academy of Neurology criteria that
control of hypertension ≤ 130/85 mm Hg is associated with a reduced risk of subsequent
ipsilateral ischemic stroke in patients with recently symptomatic carotid occlusion and
hemodynamic cerebral ischemia (increased OEF). 37 COSS patients with increased OEF
represent the most extreme case of cerebral hemodynamic compromise. Nevertheless, lower
blood pressures were associated with reduced, not increased, stroke risk. This was not
simply due to the lower blood pressure group not being hypertensive to begin with as the
hazard ratio was the same for the subgroup always treated with anti-hypertensive drugs as
for the entire cohort.
This series of studies have demonstrated that the hemodynamic status of the cerebral
circulation distal to an occluded carotid artery is the most important predictor of subsequent
stroke. Patients with the worst hemodynamic compromise (increased OEF) have a 2-year
stroke risk of 20–25%. Surgical improvement of hemodynamics by EC-IC bypass does
reduce stroke risk, but the peri-operative stoke rate is sufficiently high to nullify this benefit.
Counterintuitively, best medical management for these patients includes strict blood
pressure control.
The results of these studies also reinforce the need for empiric data. Conclusions about
therapeutic efficacy based on presumed mechanisms for stroke and for stroke therapies have
too often proven to be wrong. Research into the pathophysiology of stroke and the biological
effects of different treatments can provide the rationale for clinical trials but cannot
substitute for the empiric data in choosing individual patient therapy.
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PET scans of cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2) and
cerebral oxygen extraction fraction (OEF) in a normal subject (top row), a patient with
carotid artery occlusion and normal OEF (second row) and a patient with carotid occlusion
and high OEF before (third row) and after (bottom row) EC-IC bypass surgery.
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Kaplan-Meier cumulative occurrence curves for ipsilateral ischemic stroke from the St.
Louis Carotid Occlusion Study. Reprinted from Grubb et al,5 with permission from the
American Medical Association. Copyright 1998.
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(A)Kaplan-Meier cumulative occurrence curves for the intention-to-treat analysis of the
primary end point from the Carotid Occlusion Surgery Study. Reprinted from Powers et
al,28 with permission from the American Medical Association. Copyright 2011. (B) Kaplan-
Meier cumulative occurrence curves for the on treatment analysis of the primary end point
from the Carotid Occlusion Surgery Study with the 12 strokes that occurred within the first
two days postoperatively removed from the surgical group.
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Kaplan-Meier cumulative occurrence curves for ipsilateral ischemic stroke for 91 patients
from the non-surgical group of the Carotid Occlusion Surgery Study comparing the 41
subjects with mean blood pressures during follow-up who met the COSS target ≤ 130/85
mm Hg to the remaining 50 with higher blood pressures. Reprinted from Powers et al,37
with permission from Wolters Kluwer Health. Copyright 2014.
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Stroke Rates in the St. Louis Carotid Occlusion Study
Total Sample (n =81) Increased OEF (n=39) Normal OEF (n=42)
All Stroke -
 1 year .077 .132 .024
 2 years .190 .292 .090
Ipsilateral Stroke -
 1 year .064 .106 .024
 2 years .158 .265 .053
Reprinted from Grubb et al,5 with permission from the American Medical Association. Copyright 1998.
























Two-Year Kaplan-Meier Ipsilateral Stroke Rates from Studies Measuring OEF in Patients with
Cerebrovascular Disease
High OEF (n) Normal OEF(n)
STLCOS 19985 .265(39) .053(42)
Yamauchi 199925 .714 (7) .061(33)
Hokari 200927 .375 (9) .000(11)
COSS 201128 .223 (98)
Yamauchi 201226 .25 (16) .03 (114)
STLCOS-St. Louis Carotid Occlusion Study, COSS-Carotid Occlusion Surgery Study.
Stroke. Author manuscript; available in PMC 2015 October 01.
